Neopharm Voluntarily Delisting from Nasdaq

(Crain’s) – Neopharm Inc. is voluntarily delisting its shares from the Nasdaq, the Waukegan biotechnology company said Friday. The firm’s shares, which traded higher than $12 as recently as 2006, closed Friday at 14 cents. Its stock has declined steadily since late 2006, when the firm ...

Copyright CRAIN - Crain's
Contact Us